Artwork
iconShare
 
Manage episode 488170439 series 3310601
Content provided by HCPLive Podcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by HCPLive Podcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
In this episode of Liver Lineup: Updates & Unfiltered Insights, hosts Kimberly Brown, MD, a professor of Medicine at Michigan State University and Wayne State University, associate medical director of the Henry Ford Hospital Transplant Institute, and medical director of Transplant Outreach Services at Henry Ford Hospital, and Nancy Reau, MD, a professor of internal medicine, the Richard B. Capps Chair of Hepatology, associate director of solid organ transplantation, and the section chief of hepatology at Rush University Medical Center, continue their discussion on notable abstracts presented at the 2025 European Association for the Study of the Liver (EASL) Congress.
If you haven't already, be sure to check out part 1 here!
Key Episode Timestamps
0:00:00 LITMUS Study
0:05:47 Norursodeoxycholic Acid in PSC
0:10:12 GLOBE Score for PBC
0:15:11 Conclusion
Arbutus, and VIR. Relevant disclosures for Brown include Mallinckrodt Pharmaceuticals, Gilead, Salix, Intercept, Ipsen, and Madrigal.
  continue reading

212 episodes